Fri Jan 13, 2023 – 6:03 pm EST
(LifeSiteNews) – Moderna announced the first phase of human trials for an mRNA shot to treat those who have suffered from heart attacks amid mounting reports that the COVID mRNA shots themselves increase the risk of heart attacks.
“We are now in a super exciting program where we inject mRNA in people’s heart after a heart attack to grow back new blood vessels and re-vascularize the heart,” Moderna CEO Stéphane Bancel told Sky News in an October interview, adding, “It’s really like science fiction medicine.”
Moderna CEO Stéphane Bancel Announces New mRNA Shot to Treat Heart Failure Patients
“We are now in a super exciting program where we inject mRNA in people’s heart after a heart attack to grow back new blood vessels and re-vascularize the heart”https://t.co/kI3afoLU89 pic.twitter.com/zNw4rQN0Lv
— Chief Nerd (@TheChiefNerd) January 11, 2023
Moderna announced this week that the new mRNA treatment has been injected into the first trial participants, who have “stable heart failure,” to assess its safety and effects. The shot, mRNA-0184, encodes for relaxin, a hormone that causes changes in blood flow that are “potentially beneficial for heart failure patients.”
The
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors